SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Excess Of $100,000 Investing In American ...
September 27 2016 - 2:57PM
Business Wire
Faruqi & Faruqi, LLP, a leading national securities law
firm, reminds investors in American Renal Associates Holdings, Inc.
(“ARA”) (NYSE:ARA) of the October 31, 2016 deadline to seek the
lead plaintiff role in a federal securities class action filed
against ARA and certain officers.
The lawsuit, Gelsleichter v. American Renal Associates Holdings,
Inc. et al, No. 1:16-cv-06841, was filed on August 31, 2016 in U.S.
District Court for the Southern District of New York on behalf of
all those who purchased ARA securities: (1) pursuant to ARA’s IPO
around April 21, 2016; and/or (2) from April 21, 2016 through
August 18, 2016 (“Class Period”).
The lawsuit alleges defendants violated federal securities laws
by making misleading statements and/or failing to disclose that ARA
engaged in a scheme to steer patients from
qualified-for-Medicare-and-Medicaid plans into ACA plans to obtain
greater reimbursement for ARA’s services.
Request more information now by clicking here:
www.faruqilaw.com/ARA . There is no cost or obligation to
you.
Take Action
If you invested in ARA stock/options during the IPO and/or Class
Period and would like to discuss your legal rights, visit
www.faruqilaw.com/ARA. You can also contact Richard Gonnello via
telephone and/or e-mail, listed below.
The court-appointed lead plaintiff is the investor with the
largest financial interest in the relief sought by the class that
is adequate and typical of class members who directs and oversees
the litigation on behalf of the putative class. Any member of the
putative class may move the Court to serve as lead plaintiff
through counsel of their choice, or may choose to do nothing and
remain an absent class member. Your ability to share in any
recovery is not affected by the decision of whether or not to serve
as a lead plaintiff.
Attorney Advertising. The law firm responsible for this
advertisement is Faruqi & Faruqi, LLP (www.faruqilaw.com).
Prior results do not guarantee or predict a similar outcome with
respect to any future matter. We welcome the opportunity to discuss
your particular case. All communications will be treated in a
confidential manner.
FARUQI & FARUQI, LLP685 Third Avenue, 26th FloorNew York, NY
10017Attn: Richard Gonnello, Esq.rgonnello@faruqilaw.comTelephone:
(877) 247-4292 or (212) 983-9330
View source
version on businesswire.com: http://www.businesswire.com/news/home/20160927006611/en/
FARUQI & FARUQI, LLP685 Third Avenue, 26th FloorNew York, NY
10017Attn: Richard Gonnello, Esq.rgonnello@faruqilaw.comTelephone:
(877) 247-4292 or (212) 983-9330
American Renal Associates (NYSE:ARA)
Historical Stock Chart
From Mar 2024 to Apr 2024
American Renal Associates (NYSE:ARA)
Historical Stock Chart
From Apr 2023 to Apr 2024